ES2530623T3 - Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica - Google Patents

Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Download PDF

Info

Publication number
ES2530623T3
ES2530623T3 ES11185914T ES11185914T ES2530623T3 ES 2530623 T3 ES2530623 T3 ES 2530623T3 ES 11185914 T ES11185914 T ES 11185914T ES 11185914 T ES11185914 T ES 11185914T ES 2530623 T3 ES2530623 T3 ES 2530623T3
Authority
ES
Spain
Prior art keywords
base
tiles
vertical blade
indazolmethoxyalkanoic
prepare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11185914T
Other languages
English (en)
Spanish (es)
Inventor
Angelo Guglielmotti
Giuseppe Biondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2530623T3 publication Critical patent/ES2530623T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
ES11185914T 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Active ES2530623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002254A ITMI20062254A1 (it) 2006-11-24 2006-11-24 Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Publications (1)

Publication Number Publication Date
ES2530623T3 true ES2530623T3 (es) 2015-03-04

Family

ID=38198404

Family Applications (2)

Application Number Title Priority Date Filing Date
ES11185914T Active ES2530623T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Country Status (23)

Country Link
US (2) US8198310B2 (https=)
EP (2) EP2097080B1 (https=)
JP (1) JP5192490B2 (https=)
KR (1) KR101413616B1 (https=)
CN (1) CN101541323B (https=)
AR (1) AR063894A1 (https=)
AU (1) AU2007323351B2 (https=)
BR (1) BRPI0718522A2 (https=)
CA (1) CA2666371C (https=)
CY (1) CY1116664T1 (https=)
DK (2) DK2409698T3 (https=)
EA (1) EA016885B1 (https=)
ES (2) ES2530623T3 (https=)
GE (1) GEP20125570B (https=)
IL (1) IL198286A (https=)
IT (1) ITMI20062254A1 (https=)
MX (1) MX2009004295A (https=)
PL (2) PL2097080T3 (https=)
PT (2) PT2097080E (https=)
SG (1) SG176508A1 (https=)
SI (2) SI2409698T1 (https=)
UA (1) UA97123C2 (https=)
WO (1) WO2008061671A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
GEP20135879B (en) 2009-08-03 2013-07-10 Aziende Chimiche Riunite Angelini Francesco A C R A F S P A It Method of 1-benzyl-3-hydroxymethyl-1h-indazole preparation, derivatives thereof, and required magnesium intermediates
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2015173786A1 (en) * 2014-05-15 2015-11-19 Boyd Shelley Romayne Compositions and methods for treating and diagnosing ocular disorders
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
JP2023532888A (ja) 2020-06-27 2023-08-01 クレセンタ バイオサイエンシズ 細胞代謝を調節する化合物の組成及び使用方法
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
IT1293794B1 (it) 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
AU766219B2 (en) * 1998-02-02 2003-10-09 1149336 Ontario Inc. Method of regulating glucose metabolism, and reagents related thereto
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US20060030582A1 (en) * 2002-04-29 2006-02-09 Demartino Julie Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
AU2006243255A1 (en) * 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
EP1959982B1 (en) * 2005-12-01 2012-08-08 Flinders Technologies PTY. Ltd. Methods and compositions for preventing and/or treating pancreatitis
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Also Published As

Publication number Publication date
KR101413616B1 (ko) 2014-07-01
EP2409698B1 (en) 2015-01-21
US20100069456A1 (en) 2010-03-18
PT2409698E (pt) 2015-02-10
ITMI20062254A1 (it) 2008-05-25
EP2409698A1 (en) 2012-01-25
US20120283307A1 (en) 2012-11-08
HK1129071A1 (en) 2009-11-20
WO2008061671A3 (en) 2008-11-27
HK1165275A1 (en) 2012-10-05
AR063894A1 (es) 2009-02-25
JP5192490B2 (ja) 2013-05-08
GEP20125570B (en) 2012-07-10
CA2666371C (en) 2014-05-06
AU2007323351A1 (en) 2008-05-29
CY1116664T1 (el) 2017-03-15
CA2666371A1 (en) 2008-05-29
DK2409698T3 (en) 2015-04-27
BRPI0718522A2 (pt) 2013-11-12
PL2097080T3 (pl) 2013-07-31
US8846745B2 (en) 2014-09-30
DK2097080T3 (da) 2013-05-21
AU2007323351B2 (en) 2013-05-02
SI2409698T1 (sl) 2015-04-30
PL2409698T3 (pl) 2015-06-30
EA200970506A1 (ru) 2009-10-30
JP2010510263A (ja) 2010-04-02
IL198286A0 (en) 2010-02-17
MX2009004295A (es) 2009-05-05
EA016885B1 (ru) 2012-08-30
EP2097080A2 (en) 2009-09-09
CN101541323B (zh) 2012-01-04
EP2097080B1 (en) 2013-02-20
SI2097080T1 (sl) 2013-05-31
KR20090081410A (ko) 2009-07-28
PT2097080E (pt) 2013-04-01
WO2008061671A2 (en) 2008-05-29
US8198310B2 (en) 2012-06-12
CN101541323A (zh) 2009-09-23
UA97123C2 (uk) 2012-01-10
IL198286A (en) 2016-03-31
SG176508A1 (en) 2011-12-29
ES2403584T3 (es) 2013-05-20

Similar Documents

Publication Publication Date Title
ES2530622T3 (es) Dispositivo para la correcta colocación de baldosas
ES2530623T3 (es) Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica
USD603502S1 (en) Surgical impactor
USD673280S1 (en) Orthopedic device
USD609602S1 (en) Coupler fitting for an artificial tree segment
USD640904S1 (en) Wine aerator
USD624227S1 (en) Lighted post cap
USD606407S1 (en) Perfume bottle
PE20120596A1 (es) Recipiente de llenado en caliente
USRE45460E1 (en) Water closet
EP2225085A4 (en) LIQUID OR HYDRAULIC BLOWING
CL2011000154A1 (es) Boquilla para reabrir y cerrar un receptaculo para liquidos, que comprende una estructura cilindrica para ser unida al receptaculo, estructura que incluye una cana que tiene una seccion superior, una seccion de base y una parte superior en disposicion coaxial con la seccion superior, y una tapa para recibir la parte superior
GB2459397A (en) Water closet bolt
BR112012003158A2 (pt) "método para a utilização de árvores tamarix erect para a produção de combustível de biomassa"
EP1945069A4 (en) VERTICAL TOOL BEARING DEVICE WITH A BENT HANDLE
USD562929S1 (en) Water dispensing device
CA2690946A1 (en) Nipple for feeding liquids to calves and other mammals
DE602005011326D1 (de) Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
ITTO20060525A1 (it) Dispositivo bipolare integrato di tipo verticale e relativo procedimento per la sua fabbricazione
CN204305807U (zh) 机械宠物管家
USD583187S1 (en) Receptacle stand
CN201303541Y (zh) 一种猪用采食器
CN201379263Y (zh) 氧气表、湿化瓶存放支架
USD599734S1 (en) Solar heating apparatus
FR2918071B1 (fr) Procede d'incorporation d'alcool dans les carburants